|
|
|||||||
 |
|
|
LinkBack | Thread Tools | Display Modes |
08-04-2010, 05:23 PM
|
|||
|
|||
CEL-SCI Successfully Produces and Fills Multikine in New Manufacturing Facility
VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (NYSE AMEX: CVM) announced today that it has successfully produced and filled its first lot of Multikine in preparation for the upcoming pivotal Phase III trial targeting advanced primary head and neck cancer. The drug was filled in CEL-SCIs state-of-the-art "Cold-Fill" manufacturing facility. The Company completed this test in order to ensure ...
    
|
|
| Thread Tools | |
| Display Modes | |
|
|
Similar Threads
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| North Mississippi IRB approves CEL-SCI's Multikine Phase III clinical trial for head | cancerfr | Oral Cancer | 0 | 09-14-2010 01:25 AM |
| Catalent Pharma Soultions Provides Manufacturing And Packaging Expertise To Bioallian | cancerfr | Oral Cancer | 0 | 08-28-2010 10:51 PM |
| CEL-SCI produces and fills first lot of Multikine | cancerfr | Head and Neck Cancer | 0 | 08-05-2010 12:57 PM |
| The George Fund fills a need by focusing on children's care, not a cure | cancerfr | Brain Tumor | 0 | 08-02-2010 03:10 PM |
| Cancer plus red tape fills patient with anxiety | cancerfr | Liver Cancer | 0 | 05-03-2010 06:10 PM |
Linear Mode
